Cargando…
Toll-Like Receptor-4 Modulation for Cancer Immunotherapy
Autor principal: | Awasthi, Shanjana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110442/ https://www.ncbi.nlm.nih.gov/pubmed/25120541 http://dx.doi.org/10.3389/fimmu.2014.00328 |
Ejemplares similares
-
Diphenyldifluoroketone EF24 Suppresses Pro-inflammatory Interleukin-1 receptor 1 and Toll-like Receptor 4 in lipopolysaccharide-stimulated dendritic cells
por: Vilekar, Prachi, et al.
Publicado: (2015) -
Lung and general health effects of Toll-like receptor-4 (TLR4)-interacting SPA4 peptide
por: Awasthi, Shanjana, et al.
Publicado: (2020) -
Toll-like Receptors in Ovarian Cancer as Targets for Immunotherapies
por: Muccioli, Maria, et al.
Publicado: (2014) -
Editorial: Updates on toll-like receptors in cancer immunity and immunotherapy
por: Hoden, Bettina, et al.
Publicado: (2023) -
Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy
por: Kirtland, Max E., et al.
Publicado: (2020)